Firethorn Wealth Partners LLC Grows Position in GE HealthCare Technologies Inc. $GEHC

Firethorn Wealth Partners LLC lifted its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 83.5% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 4,746 shares of the company’s stock after purchasing an additional 2,160 shares during the quarter. Firethorn Wealth Partners LLC’s holdings in GE HealthCare Technologies were worth $352,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors also recently bought and sold shares of GEHC. JPMorgan Chase & Co. boosted its holdings in GE HealthCare Technologies by 49.9% during the 1st quarter. JPMorgan Chase & Co. now owns 5,140,549 shares of the company’s stock valued at $414,894,000 after acquiring an additional 1,711,963 shares during the period. Nuveen LLC purchased a new position in GE HealthCare Technologies during the 1st quarter valued at about $77,058,000. Eminence Capital LP boosted its holdings in GE HealthCare Technologies by 38.7% during the 1st quarter. Eminence Capital LP now owns 1,819,129 shares of the company’s stock valued at $146,822,000 after acquiring an additional 507,101 shares during the period. Homestead Advisers Corp boosted its holdings in GE HealthCare Technologies by 92.7% during the 1st quarter. Homestead Advisers Corp now owns 988,600 shares of the company’s stock valued at $79,790,000 after acquiring an additional 475,500 shares during the period. Finally, Canada Pension Plan Investment Board boosted its holdings in GE HealthCare Technologies by 15.2% during the 1st quarter. Canada Pension Plan Investment Board now owns 3,111,398 shares of the company’s stock valued at $251,121,000 after acquiring an additional 409,636 shares during the period. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

GE HealthCare Technologies Trading Down 0.3%

Shares of GEHC stock opened at $76.56 on Friday. The business’s 50 day moving average is $74.25 and its two-hundred day moving average is $72.54. GE HealthCare Technologies Inc. has a twelve month low of $57.65 and a twelve month high of $94.80. The company has a market capitalization of $34.95 billion, a P/E ratio of 15.69, a price-to-earnings-growth ratio of 2.93 and a beta of 1.13. The company has a current ratio of 1.16, a quick ratio of 0.93 and a debt-to-equity ratio of 0.85.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Wednesday, July 30th. The company reported $1.06 earnings per share for the quarter, beating the consensus estimate of $0.91 by $0.15. GE HealthCare Technologies had a return on equity of 23.93% and a net margin of 11.22%.The company had revenue of $5 billion for the quarter, compared to the consensus estimate of $4.96 billion. During the same period last year, the business posted $1.00 EPS. The company’s revenue was up 3.5% on a year-over-year basis. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. Equities analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 24th will be paid a $0.035 dividend. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. The ex-dividend date is Friday, October 24th. GE HealthCare Technologies’s dividend payout ratio (DPR) is 2.87%.

Wall Street Analyst Weigh In

A number of brokerages recently commented on GEHC. Zacks Research cut GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a report on Monday, September 29th. Weiss Ratings restated a “hold (c)” rating on shares of GE HealthCare Technologies in a report on Saturday, September 27th. Citigroup lifted their price objective on GE HealthCare Technologies from $89.00 to $93.00 and gave the company a “buy” rating in a research note on Thursday, July 31st. Wall Street Zen cut GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, September 20th. Finally, Morgan Stanley set a $74.00 price objective on GE HealthCare Technologies in a research note on Thursday, September 18th. Seven analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $86.89.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.